Zantac Bladder Cancer

The Food and Drug Administration (FDA) recently withdrew Zantac – and other ranitidine products – from the market because the popular heartburn and GERD medication contains the contaminate NDMA (N-Nitrosodimethylamine). NDMA has been deemed a probable carcinogen – cancer-causing agent – by the Environmental Protection Agency (EPA), the World Health Organization (WHO), and many other national and international health organizations. One of the cancers associated with this dangerous contaminant is bladder cancer.

The Connection to Bladder Cancer

There are a wide variety of scientific studies and research analysis that connect the NDMA found in Zantac and generic versions of the medication with bladder cancer (most are related to NDMA found in drinking water), including:

• An important test performed by researchers from the Ontario Cancer Institute
• The S. Iowa Women’s Health Study
• Several animal studies noted by WHO

Bladder Cancer Symptoms

The Mayo Clinic shares the symptoms that are most closely associated with bladder cancer:

• Blood in the urine, which is known as hematuria
• Pain in the pelvic region
• Pain upon urination

If you are experiencing any of these symptoms (or any symptoms that concern you), It’s critical that you seek medical attention.

An Experienced Drug Injury Attorney Can Help

If you took Zantac regularly and have been diagnosed with bladder cancer, there could be a connection. Working closely with a dedicated drug injury attorney with extensive experience successfully going up against the big drug companies will help ensure that you obtain the compensation to which you are entitled.